Journal of Enzyme Inhibition and Medicinal Chemistry

Taylor & Francis Group

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Journal of Enzyme Inhibition and Medicinal Chemistry is an open-access journal published by Taylor & Francis Group in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,165 AUD. Declared review time at DOAJ: 26 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Taylor & Francis Group
ISSN
1475-6366 · 1475-6374
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
4,165 AUD
Articles in DOAJ
1559
Declared review time
26 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2017-09-27
  • MEDLINE · 2002-01-01
  • PUBMED · 2008-10-01
Indexing
DOAJ · MEDLINE · PUBMED
APC
4,165 AUD
Declared review time (DOAJ)
26 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

1559

Most recent article

last month

Average review time (journal-declared via DOAJ)

26weeks

Works in OpenAlex

3489

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

107

i10-index

2384

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2024-08-08
Added to DOAJ
2017-09-27
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSLOCKSSPMCPorticoScholars Portal
Observed digital preservation (Keepers registry)— snapshot 2026-09-21
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
97%
ORCID iDs in current deposits
28%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
J. enzym. inhib.Enzyme inhibition and medicinal chemistry
Source type
journal
NLM unique ID (PubMed)
101150203
Classification2

Subjects (DOAJ)

Medicine: Therapeutics. Pharmacology

LCC codes

RM1-950

Subject areas

  • Synthesis and biological activity
  • Synthesis and biological activity
  • Enzyme function and inhibition
  • Enzyme function and inhibition
  • Cholinesterase and Neurodegenerative Diseases
  • Cholinesterase and Neurodegenerative Diseases
  • Synthesis and Catalytic Reactions
  • Synthesis and Catalytic Reactions
Show all subjects (50)
  • Computational Drug Discovery Methods
  • Synthesis and Biological Evaluation
  • Synthesis and Biological Evaluation
  • Computational Drug Discovery Methods
  • Phenothiazines and Benzothiazines Synthesis and Activities
  • Phenothiazines and Benzothiazines Synthesis and Activities
  • Cancer therapeutics and mechanisms
  • Cancer therapeutics and mechanisms
  • Click Chemistry and Applications
  • Click Chemistry and Applications
  • Bioactive Compounds and Antitumor Agents
  • Bioactive Compounds and Antitumor Agents
  • Quinazolinone synthesis and applications
  • Quinazolinone synthesis and applications
  • Synthesis and Characterization of Heterocyclic Compounds
  • Synthesis and Characterization of Heterocyclic Compounds
  • Metal complexes synthesis and properties
  • Metal complexes synthesis and properties
  • Chemical Reactions and Mechanisms
  • Chemical Reactions and Mechanisms
  • Phytochemicals and Antioxidant Activities
  • Phytochemicals and Antioxidant Activities
  • Peptidase Inhibition and Analysis
  • Peptidase Inhibition and Analysis
  • Biochemical and Molecular Research
  • Biochemical and Molecular Research
  • Free Radicals and Antioxidants
  • Free Radicals and Antioxidants
  • Natural product bioactivities and synthesis
  • Natural product bioactivities and synthesis
  • Research on Leishmaniasis Studies
  • Research on Leishmaniasis Studies
  • HIV/AIDS drug development and treatment
  • HIV/AIDS drug development and treatment
  • melanin and skin pigmentation
  • melanin and skin pigmentation
  • Protein Degradation and Inhibitors
  • Protein Degradation and Inhibitors
  • Natural Antidiabetic Agents Studies
  • Natural Antidiabetic Agents Studies
  • Carbohydrate Chemistry and Synthesis
  • Carbohydrate Chemistry and Synthesis

Keywords (DOAJ)

  • enzymology
  • cell biology
  • chemical biology
  • microbiology
  • physiology
  • pharmacology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: